🕒 Friday 13 June 2025 Fri, 13 June 2025

Clarity Pharmaceuticals’ novel PET imaging agent Cu-SAR-Bombesin demonstrated safety and effectiveness in detecting prostate cancer recurrence missed by standard scans in its Phase II SABRE trial. The agent identified lesions in about one-third of patients with negative or equivocal standard imaging.

Invion Limited launches a Loyalty Option entitlement offer aimed at raising up to $16 million to support its advancing cancer clinical trials, including a promising anogenital cancer study with Peter MacCallum Cancer Centre.

EDU Holdings reports a remarkable 118% increase in total student enrolments at its Ikon Institute for Trimester 2, 2025, driven by strong demand and new course offerings amid a shifting regulatory landscape.

New World Resources has successfully completed a placement of 32 million shares at $0.02 each to its board and senior management, following shareholder approval. This move subtly reshapes the company’s capital structure ahead of its copper and base metals projects in the US.

Saunders International announces the planned resignation of CEO Mark Benson by year-end alongside a notable downgrade in FY25 revenue and earnings guidance due to project delays and weather disruptions.

CLINUVEL Pharmaceuticals announces the full-time return of Managing Director Dr Philippe Wolgen, focusing on advancing critical product development and corporate initiatives, while Acting CEO Lachlan Hay continues until September 2025.

Brazilian Critical Minerals has achieved a significant milestone in its Ema project by successfully demonstrating magnesium sulphate migration and pH reduction in field trials, validating its in-situ recovery method for rare earth elements.

Thrive Tribe Technologies has announced a proposed 20, 1 share consolidation aimed at streamlining its capital structure, pending shareholder approval at the upcoming Extraordinary General Meeting.

Viridis Mining and Minerals has been selected for a major Brazilian government funding package to accelerate its Colossus rare earth elements project, marking a pivotal step in diversifying global critical mineral supply chains.

Qualitas Real Estate Income Fund has declared its May 2025 distribution, offering investors a 7.42% annualized return based on net tangible assets. The fund continues to focus on Australian real estate loans secured by mortgages.

Carnaby Resources has revealed preliminary VTEM survey results identifying multiple new conductors at its Greater Duchess Copper Gold Project, highlighting promising targets in a largely unexplored southern corridor.

AdAlta Limited has successfully placed the remaining shortfall in its renounceable rights issue, raising a total of $1.3 million to advance its cellular immunotherapy pipeline. The company also addressed an administrative breach involving director share allocations, ensuring compliance with ASX rules.

Euroz Hartleys Group Limited has announced a proposed $23 million capital return to shareholders, pending approval at a July 2025 meeting, aiming to streamline its corporate structure while maintaining financial strength.

Meteoric Resources has secured inclusion in Brazil’s major Strategic Minerals funding program, aiming to advance its Caldeira Rare Earths Project and downstream magnet production.

Ionic Rare Earths’ Brazilian joint venture, Viridion, has been selected for significant government funding to accelerate rare earth refining and magnet recycling, marking a major step in Brazil’s strategic push for a secure, sustainable supply chain.

Macarthur Minerals has relaunched a renounceable rights issue to raise nearly A$2 million, fully underwritten by Gold Valley, aiming to fund its Lake Giles Iron Project and strengthen its balance sheet.

Ballymore Resources’ latest drilling at the Dittmer Project in north Queensland has uncovered exceptional bonanza-grade gold intersections, including a staggering 221.31 g/t gold over 0.4 metres. The company is now preparing to test a deep porphyry target that could redefine the project’s potential.

Macarthur Minerals Limited has issued a replacement prospectus for a renounceable entitlement offer aiming to raise approximately AUD 2 million, fully underwritten by Gold Valley Yilgarn Pty Ltd. The offer includes free attaching options and supports the company’s exploration and operational funding needs.

Terra Metals has raised $4 million through a strategic placement, attracting heavyweight investors to accelerate exploration at its Dante Project in Western Australia.

Metgasco Ltd has successfully raised approximately $750,000 through a partially underwritten entitlement offer to fund a production uplift program targeting its Odin and Vali gas fields in the Cooper Eromanga Basin.

Western Gold Resources has voluntarily suspended its shares from trading as it prepares to disclose details of a significant agreement and respond to an ASX price query.

African Gold Ltd has completed a strategic investment with Montage Gold Corp, involving a share swap and private placement worth approximately A$9.2 million, reshaping ownership stakes between the two miners.

Dimerix has reached a key milestone by dosing 200 adult patients in its Phase 3 ACTION3 trial for FSGS, progressing steadily toward full recruitment expected in late 2025.

Heavy Rare Earths Limited has validated a significant uranium anomaly at its Perenjori project in Western Australia, with soil assays reaching up to 116 ppm uranium. The company is preparing to drill and test this promising target, which compares favorably with established regional uranium deposits.